314 related articles for article (PubMed ID: 8058318)
1. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
Kitagawa M; Higashi H; Takahashi IS; Okabe T; Ogino H; Taya Y; Hishimura S; Okuyama A
Oncogene; 1994 Sep; 9(9):2549-57. PubMed ID: 8058318
[TBL] [Abstract][Full Text] [Related]
2. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Kitagawa M; Okabe T; Ogino H; Matsumoto H; Suzuki-Takahashi I; Kokubo T; Higashi H; Saitoh S; Taya Y; Yasuda H
Oncogene; 1993 Sep; 8(9):2425-32. PubMed ID: 8395680
[TBL] [Abstract][Full Text] [Related]
3. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
Braunagel SC; Parr R; Belyavskyi M; Summers MD
Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic.
Kakeya H; Onose R; Liu PC; Onozawa C; Matsumura F; Osada H
Cancer Res; 1998 Feb; 58(4):704-10. PubMed ID: 9485024
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
6. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
Gonzales AJ; Fry DW
Exp Cell Res; 2005 Feb; 303(1):56-67. PubMed ID: 15572027
[TBL] [Abstract][Full Text] [Related]
7. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
Amellem O; Stokke T; Sandvik JA; Pettersen EO
Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457
[TBL] [Abstract][Full Text] [Related]
8. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
[TBL] [Abstract][Full Text] [Related]
9. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
10. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.
Lucas JJ; Terada N; Szepesi A; Gelfand EW
J Immunol; 1992 Mar; 148(6):1804-11. PubMed ID: 1541821
[TBL] [Abstract][Full Text] [Related]
11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
14. Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.
Eblen ST; Fautsch MP; Anders RA; Leof EB
Cell Growth Differ; 1995 Aug; 6(8):915-25. PubMed ID: 8547220
[TBL] [Abstract][Full Text] [Related]
15. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
[TBL] [Abstract][Full Text] [Related]
17. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
Van Dolah FM; Ramsdell JS
J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
[TBL] [Abstract][Full Text] [Related]
18. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130.
Mayol X; Garriga J; GraƱa X
Oncogene; 1995 Aug; 11(4):801-8. PubMed ID: 7651744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]